In this preclinical study in mouse models, LM impaired the survival of CD56-expressing MM cells in a dose-dependent manner by causing cytotoxicity associated with G2-M cell cycle arrest and leading to apoptosis, while CD56-negative tumor cells remained unharmed. Here, NCAM1 is linked to neoplasm.